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NK cell cytolytic activity is enhanced afterexposure to IFN and/or IFN inducers
in vitro (1, 2) and in vivo (3-6) . In vitro, IFN induces NK cell cytotoxicity on a
per cell basis (1, 2) . In vivo, IFN not only enhances the level of killing mediated
by individual cells, but also induces the blastogenesis and proliferation ofNK cells
(3-6) . NK cell blastogenesis is observed during viral infections at times coinciding
with the production of antiviral IFNs (3-5), after treatment with the IFN-inducer,
polyinosinic-polycytidylic acid [poly(I:C)]' (5, 6), and after in vivo administration
ofexogenous IFN (6) . We have extensively characterized NK cell blastogenesis and
proliferation, and have documented the following changes inNK cells induced by
exposure to IFN in vivo : (a) increased size (3, 4, 6) and decreased density (7); (b)
increased sensitivity to the cell cycle-specific toxin, hydroxyurea (4); (c) entry into
S andG2/M phases of the cell cycle (8, 9) ; (d) enhanced incorporation of theDNA
precursor [3H]thymidine by cells directly mediating lysis ofNK target cells (3, 6) ;
and (e) increased total numbers ofNK cells per spleen (9) . Taken together, these
results conclusively demonstrate the proliferation ofNK cells in response to IFNs
in vivo. It has not been possible, however, to directly support NK cell expansion
in vitro with IFN, suggesting that IFN does not act directly as a growth factor for
NK cells . Thus, IFN-induced NK cell expansion appears to involve an as yet
unidentified endogenous mediator whose production, activation, and/or effective-
ness in vivo is linked to IFN .
TheTcell growth factor IL-2 can directly induce NK cell activation and prolifer-
ation in vitro (10-12) and in vivo (8), and is a candidate to mediateendogenous NK
cell responses . IL-2 is a product of mature, activated T cells, and T cells are pre-
sumed to be the major physiological source of the factor. During virus infection,
IL-2 is produced in vivo with kinetics corresponding to those ofT cell activation
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and expansion (13). Both CD4+ and CD8+ T lymphocytes contribute to endoge-
nous IL-2 production during lymphocytic choriomeningitis virus (LCMV) infec-
tion (13, 14). Under certain conditions of in vitro stimulation, additional cell types
may produce IL-2. Splenic B cells(15), B cell lines (15, 16), and cellswith large granular
lymphocyte (LGL) morphology (17) have all been reported to make IL-2 in vitro.
The significance ofalternative sources of IL-2 has yet to be evaluated in vivo. During
virus infection (3) and after treatment with poly(I:C) (9), NK cell activation and
proliferation are observed in athymic mice lacking mature T cells. Thus, if IL-2
is required for IFN-induced NK cell responses, cells other than T cells would have
to be sources of the factor in vivo.
In this report, we investigate the role of IL-2 during NK cell division in response
to poly(I:C)-induced IFN in vivo. For these studies, the proliferation of NK cells
was examined in T cell-deficient athymic nu/nu mice. Blast NK cells were enriched
in the B cell-depleted low density mononuclear cell population isolated from the
spleens of mice treated with poly(I :C). These cells were able to recognize IL-2 and
proliferate in response to the factor, but responsiveness required 1,000-fold higher
levels of IL-2 than was required by blast T cells elicted in vivo. To evaluate in vivo
induction ofIL-2 under conditions of NK cell proliferation, IL-2 gene transcription
was analyzed by in situ hybridization in cells isolated from mice treated with the
IFN inducer. Poly(I:C) stimulated IL-2 gene expression in a small population of
leukocytes isolated from euthymic and athymic animals, as well as in cells isolated
from mice with severe combined immunodeficiency (SLID). Cyclosporin A (CsA),
an inhibitor of IL-2 transcription and production (18, 19), was used to examine the
requirement for IL-2 transcription during NK cell proliferation. Although CsA
abrogated poly(I :C)-induced IL-2 gene expression in athymic mice, it did not block
NK cell activation or proliferation. These results indicate that IL-2 may be induced
in response to IFNs, but that the factor is not a major mediator of NK cell expansion
during the acute proliferative response to IFNs in vivo. Moreover, these results dem-
onstrate that NK cell proliferation and the factor(s) supporting it in vivo are CsA
insensitive.
Materials and Methods
Mice.
￿
Specific pathogen-free athymic nu/nu mice (BALE/cAnBOM) and their nu/+ lit-
termates were bred in strict isolation in our facilities at Brown University. Young mice were
used (6-10 wk of age) to avoid age-associated accumulation of T cells in the periphery (20).
SLID (C.B-17, scid/scid) mice were a generous gift of Dr. Joan Stein-Streilein, University
of Miami School of Medicine, Miami, FL. The C3H/HeNTacfBR mice were purchased from
Taconic Laboratory Animals and Services, Germantown, NY.
In Vivo Treatment Protocols.
￿
Mice were treated with 100 lug ofpoly(I:C) (Sigma Chemical
Co., St. Louis, MO) by intraperitoneal injection 1.5 d before death (5, 8). Activated T cells
were prepared from C3H mice on day 7 post-infection with 104 PFU of Armstrong strain
LCMV, as described previously (13).
In Viao Depletion ofAGMI-positive Cells.
￿
To deplete NK cells in vivo, mice were given a
single intraperitoneal injection of antibody to AGMI (21) (Wako Chemicals, Inc., Dallas,
TX) 1.5 d before poly(I :C) (3 d before death), as described previously (5, 7). These condi-
tions have been shown to specifically deplete NK cells in vivo (5, 22).
CsA Treatment.
￿
CsA (Oral solution, 100 mg/ml in olive oil-labrafil base; Batch 093L5;
kindly provided by Dr. David Winter, Sandoz Pharmaceuticals, Hanover, NJ) was diluted
in olive oil (Sigma Chemical Co.). Mice were given three dosages of 40 mg/kg each by in-
traperitoneal injection at 12-h intervals. The first dose was given 2 h before administrationKASAIAN AND BIRON
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of poly(I:C). Three dosages of 40 mg/kg CsA have been shown to profoundly inhibit CTL
activity, T cell proliferation, and IL-2 production during infection of mice with LCMV (14).
Control animals for these experiments received an equal volume ofolive oil in place ofCsA.
Preparation ofCellsfor Analysis.
￿
Mice were killed by cervical dislocation, and their spleno-
cyteswere harvested. RBC were lysed by ammonium chloride treatment. Low density leuko-
cytes were isolated at the interface of a 38-54% discontinuous Percoll density gradient (5).
In some cases, the splenocyte populations were depleted of B cells and polymorphonuclear
leukocytes (PMNs) by treatment with the mAb J11d (23) and C', as described (5). Viable
cells were collected by centrifugation through 38% Percoll. This was followed by a 38-54%
discontinuous Percoll density gradient to isolate low density, J11d- cells.
5X-Chromium Release Cytotoxicity Assay.
￿
The NK-sensitive target cell line, YAC-1, was la-
beled with sodium "Cr (ICN, Irvine, CA), and incubated with effector cells for 5 h at 37oC
in microtiter plates, as described (7). Spontaneous lysis was determinedby incubating medium
with the target cells. Maximum
51Cr release was determined by adding 1% NP-40 to target
cells. Percentage of lysis was calculated as: 100 x (cpm test sample - cpm spontaneous
lysis)/(cpm maximum release - cpm spontaneous lysis). A lytic unit (LU) was calculated
as the number of effector cells required to mediate 20% target cell lysis.
Single Cell Cytotoxicity Assay.
￿
The Jlld- low density splenocytes, prepared as described
above, were labeled with the DNA precursor, ['H]thymidine (60-90 Ci/mmol; ICN) for 1 h
at 37°C. The labeled effector cells were used in a single cell-killing assay with autoradiog-
raphy, as previously described (3, 4). Briefly, the effector cells were mixed with K562 target
cells at an E/T cell ratio of 1 :1, pelleted, and incubated for 30 min at room temperature
to allow E/T cell conjugate formation. K562 target cells, previously shown to be sensitive
to lysis by murine NK cells (3, 6), were used because their large size made them easily distin-
guishable from the smaller size effector cells. The conjugates were resuspended in 0.5,70 agarose
(Sea-Plaque, low gelling temperature; FMC Corp., Rockland, ME) and spread in a thin layer
over agarose-coated microscope slides. The slides were incubated at 37 oC for 4 h to allow
for cytotoxicity, stained with 0.1% trypan blue (Gibco Laboratories, Grand Island, NY) to
visualize dead cells, extensively washed, and fixed in 0.1% formaldehyde. Slides were coated
in nuclear track emulsion (type NTB-2; Kodak, Rochester, NY), exposed for 2 d, and devel-
oped. 100 conjugates, composed of a single effector and single target cell, were scored per
slide. Percent cytotoxicity was quantitated by determining the fraction of E/T cell conjugates
containing a dead target cell. The percentage of killing mediated by blast effector cells was
determined as: 100 x (number of conjugates containing a dead target cell bound to a blast
effector cell)/(total number of conjugates containing a dead target cell).
In Situ Hybridization.
￿
The plasmid pmIL2-20 (24), containing 530 nucleotides of mouse
IL-2 cDNA, was obtained through Dr. Gayle Woloschak of the Argonne National Labora-
tory, Argonne, IL, and used for in situ hybridization, as described (13). Northern blot anal-
ysis confirmed that the probe hybridized to the 12S mouse IL-2 transcript. The probe was
labeled with :isS dCTP (New England Nuclear, Boston, MA) by random hexanucleotide
priming (kit from Boehringer-Mannheim Biochemicals, Indianapolis, IN) to a sp act of >10s
cpm/Wg, and added to a mixture of salmon sperm DNA and brewer's yeasttRNA. The nucleo-
tide mixture was dehydrated, and denatured in 100% formamide at 900C . The cells to be
probed were spun onto microscopeslides using a cytocentrifuge (Shandon Southern Instru-
ments Inc., Sewickley, PA), fixed in 4o7o paraformaldehyde, dehydrated, and stored in 70%
ethanol. They were rehydrated in PBS before hybridization, then treated with 50% forma-
mide at 700C for 5 min. Hybridization was performed at 37oC for 3 h. The cells were washed
extensively in formamide and SSC (3 M sodium chloride, 0.3 M sodium citrate, pH 7.0)
at 4°C. The slides were dried, dipped in nuclear track emulsion (type NTB-2; Kodak), ex-
posed at 4oC for 7-10 d, and developed. After autoradiography, the cells were stained with
Wright's-Giemsa. The specificity of the technique was demonstrated by the following criteria:
(a) a high degree of specific hybridization of the IL-2 probe to Con A-induced T cell blasts,
shown to be IL-2 transcription positive by Northern blot analysis; (b) lack of hybridization
ofcells positive for IL-2 transcription to vector control DNA (pGEM-1, digested to the same
size and labeled to the same specific activity as the IL-2 probe); and (c) lack ofhybridization
ofa probe directed against the /3 constant region of the TCR gene to nu/nu spleen cells, posi-
tive for hybridization to the IL-2 probe.748
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Lymphocyte Proliferation Assay.
￿
Splenocytes were plated in microtiter wells (105 cells/well)
in the absence of additional growth factors or mitogens. ['H]Thymidine (1 ACi/well; ICN)
was immediately added. After a 6-h incubation at 37 °C, the cells were harvested using a
Mini-MASH II (Whittaker M. A. Bioproducts, Walkersville, MD). Incorporation of
['H]thymidine was assayed by liquid scintillation counting.
Single Cell PHIThymidine Incorporation.
￿
Spleen cells were incubated at 106/ml in medium
containing 2.5 pCi/ml ['H]thymidine (ICN). After a 1-h incubation at 37°C, the cells were
washed four times, and spun onto microscope slides usinga cytocentrifuge. Cells were fixed
in 4% paraformaldehyde for 15 min at room temperature, rinsed in 70% ethanol, and air
dried. The slides were dipped in nuclear track emulsion (type NTB-2 ; Kodak), exposed at
4°C for 24 h, developed, and stained with Wright's-Giemsa.
IL-2 Responsiveness Assay.
￿
Cells were incubated at 105/well in microtiter plates with the
indicated concentration of human rIL-2 (a gift ofCetus Corp., Emeryville, CA). Concentra-
tions of IL-2 are reported as Cetus units (the specific activity of the rIL-2 was 3 x 106 Cetus
units per mg protein, where 3 Cetus units = 18 IU). Cells were incubated for 24 h, with
['H]thymidine (1 p.Ci/well; ICN) added for the final 6 h of incubation . Cells were harvested
from plates using a Mini-MASH II, and incorporation of the DNA precursor was deter-
mined by liquid scintillation counting.
Determination of Lymphocyte Morphology.
￿
Cells were spun onto microscope slides using a
cytocentrifuge (30,000-50,000 cells per slide). Centrifugation was performed at 400 rpm for
5 min. Cells were stained with Wright's-Giemsa, and morphology was examined.
Results
NK Cell Activation and Proliferation in Response to Poly(I:C).
￿
These experiments were
undertaken to evaluate the role ofIL-2 in mediating IFN-induced NK cell responses
in vivo. The IFN inducer poly(I :C) stimulates NK cell activation and expansion
in both athymic and euthymic mice (5, 6). To examine NK cell responses in the
absence of T cells and T cell interactions, athymic (nu/nu) mice were treated with
poly(I :C). As reported previously (5, 6), poly(I:C) treatment resulted in enhanced
NK cell cytotoxic activity against the NK-sensitive target cell line, YAC-1 (Table
I; Fig. 1 A). An average of 24 LU/spleen were produced. As these experiments re-
quired quantitation of NK cell numbers and analysis of NK cell division, it was
necessary to establish protocols for enrichment of the NK cell subset. Density sepa-
rations and subset depletions were used to isolate the activated NK cell population.
Cells mediating YAC-1 lysis were enriched among low density splenocytes isolated
from poly(I:C)-treated animals (Table I). The low density fraction represented 20-25%
ofthe total spleen cell population isolated from poly(I:C)-treated, as well as control,
athymic mice. Depletion of B cells and PMNs with the mAb, Jlld, and C' resulted
in a further enrichment of cells mediating lysis in the low density fraction (Table
I). The J11d - low density population corresponded to 2-14% of the total spleen leu-
kocytes from control athymic mice, and 3-5% of the total from poly(I:C)-treated
animals.
NK cell blastogenesis and proliferation after poly(I:C) treatment were assayed
by analysis of LGL numbers, and by incorporation of the DNA precursor, [3H]thy-
midine. The percentage of cells with the LGL morphology, characteristic of NK,
was dramatically increased in the Jlld- low density cell fraction after poly(I:C) treat-
ment (Table I; Fig. 1 B). The total number of LGLs in this fraction more than dou-
bled as a result of this treatment, from 3 .4 x 105 in control animals to 1 .5 x 106
in mice treated with poly(I :C). Lymphocytes undergoing DNA synthesis were also
greatly enriched in the Jlld- low density population (Table I; Fig. 1 C). Thesed
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FIGURE 1 .
￿
Effects of in vivo anti-AGMI treat-
ment on poly(I:C)-induced responses . Athymic
(nu/nu) mice were treated with antiserum to
AGMI 3 d before death . Poly(I:C) was admin-
istered 1 .5 d later. Spleen leukocytes were har-
vested and fractionated as described in Materials
and Methods . Responses were compared with
those ofuntreated control mice, mice given anti-
body only, and mice given poly(I:C) only. (A)Cy-
totoxicity mediated by total plastic nonadherent
cells in a 5-h S'Cr release assay against YAC-1
target cells . (B) Percentages of cells with LGL
morphology in the J11d- lowdensity fraction . A
total of200 cells were scored per sample. (C) In-
corporation of [ 3Hlthymidine by freshly isolated
Jlld - lowdensity cells in a 6-h pulse. Data are
the mean +/- SD for 5-10 replicates per sample.
results demonstrate that NK cells and dividing cells are enriched in low density
J11d- populations after treatment with the IFN inducer.
The dividing cells were characterized as the NK cells by in vivo administration
of antibody against theNK cell marker, AGMI . This treatment eliminated poly(I:C)-
induced NK cytotoxicity (Fig . 1 A), cells with LGL morphology (Fig. 1 B), and
cells incorporating [ 3H]thymidine (Fig . 1 C) . In additional experiments, the
[3H]thymidine-incorporating cells were shown to directly mediate lysis of NK-
sensitive target cells in a single cell-killing assay with autoradiography (Table II) .
Of the 40% cytotoxicity mediated by poly(I:C)-activated NK cells, 54% was due
to effector cells undergoing division . Taken together, these findings establish that
the dividing J11d - low density cells are NK cells, and support our previous work
demonstratingNK cell expansion after treatment with IFN inducers in vivo (3-6) .A4-h single cell cytotoxicity assay with autoradiography wasperformed as described in Materi-
als andMethods, using effector cells labelled with the DNA precursor, [3H]thymidine, and
K562 target cells. 100 E/Tcell conjugates were scored per assay. Dead targets were visual-
ized by staining with trypan blue. Blast effector cells, which had incorporated [-'H]thymi-
dine, were visualized by autoradiography with nuclear track emulsion.
J1 Id- low density spleen leukocytes, prepared from athymic mice as described in Materials
and Methods, were used as effector cells.
l Calculated as 100 x (number ofconjugates containing dead targets and blast effector cells)/
(number of total conjugates containing dead target cells), for 100 total conjugates scored.
Mice were treated with 100 pg poly(I :C) intraperitoneally 1.5 d before death.
IL-2Responsiveness ofNKCellsin Poly(I:C)-treatedMice.
￿
To determinewhether the
IFN-activated cells from nude mice were able to recognize and respond to IL-2,
incorporation of [3H]thymidine was assayed after exposure to IL-2 in vitro. IL-2
responsiveness was found, but only among the low density Jlld- subset enriched
for NK cells. The concentration dependence of IL-2-supported proliferation was
examined. TheJ11d- low density cells isolated from control mice did not proliferate
in response to IL-2 concentrations ofup to 2.5 x 105 U/ml. When these cells were
exposed to levels >5 x 105 U/ml, however, proliferation was observed (Fig. 2).
Similar results were found using cells prepared from either euthymic or athymic
animals. TheJIM- low density cells isolated from poly(I:C)-treated athymic mice
responded to lower levels ofthe factor, requiring -2.5-5 x 103 U/ml rIL-2 forhalf-
maximal proliferation (Fig. 2). The responding cell type was characterized as NK
based on its sensitivity toin vivo anti-AGMI treatment (Fig. 3). Wehave previously
shown that dividing spleen T cells, activated during LCMV infection, are induced
to respond to IL-2 (14). The JIM- low density spleen cells isolated from euthymic
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TABLE II
Cytotoxic Activity of Blast Elector Cells in a Single Cell Assay
FIGURE 2.
￿
Responsiveness of
poly(I:C)-elicited blast cells to
IL-2. The Jlld- low density
cells were isolated, and in-
cubated for 24 h with the indi-
cated concentrations of rIL-2
(Cetus Corp.) Theproliferative
response of the cells was deter-
mined by addition of [3H]thy-
midine for the final 6 hofincu-
bation. Cellswere derived from
athymic (nu/nu) mice treated
with poly(I:C) (0), untreated
euthymic (C3H)mice (*), and
C3H mice 7 d post-infection
with LCMV (0).
Dead target cells Dead target cells
conjugated to conjugated to Killing mediated by
Effector cells" effector cells (total) blast effector cells blast effector cellsl
0 /0
Control 6.3 t 4.0 0.3 t 0.6 5 .7
Poly(I:C)S 39.7 t 4.7 21 .3 f 5.0 53 .8752
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mice at the peak of theT cell response, day 7 post-infection with LCMV, were pre-
pared for comparison . ActivatedTcells required -2.5-5 U/ml rIL-2 forhalf-maximal
proliferation (Fig . 2) . Thus, IFN-induced NK cells are responsive to IL-2, but re-
quire 1,000-fold higher concentrations ofthe factor than those required forthe prolifer-
ation of in vivo activated T cells .
Induction ofIL-2 Gene Transcription by Poly(I-C) .
￿
To determine if IFN-inducedNK
cell blastogenesis is accompanied by induction of IL-2, in situ hybridizations were
performed to examine the activation of IL-2 gene expression . Hybridizations were
carried out on paraformaldehyde-fixed cells usingacDNA probe to themouse IL-2
gene . Low but significant percentages of cells isolated from poly(I:C)-treated, but
not from untreated, athymic mice expressed the IL-2 gene (Table III) . As we have
previously demonstrated IL-2 gene expression in spleen T cells of euthymic mice
during infection with LCMV, poly(I:C)-mediated induction ofIL-2 expression was
also examined in euthymic (nu/+ ) mice . A low percentage of expressing cells were
also found in spleens ofnu/+ mice treated with the IFN inducer (Table III) . Thus,
IFN induction in vivo, under conditions that promote NK cell proliferation, is ac-
TABLE III
FIGURE 3 .
￿
Administration ofanti-AGM1 in vivo
eliminates IL-2 responsiveness in poly(I:C)-
treated mice. Athymic (nu/nu) mice were treated
with antiserum to AGM1 3 d before death, and
given poly(I:C) 1.5 d later. Spleen leukocytes were
harvested, and theJlld - low density fraction pre-
pared as described in Materials and Methods .
Cells were incubated with 5 x 10 3 U/ml rIL-2
(Cetus Corp.) for 24 h . Proliferation of the cells
in response to IL-2 was determined by addition
of [ 3H]thymidine for the final 6 h of incubation .
In the absence of exogenous IL-2, [3Hithymi-
dine incorporation ranged from 460 to 3,187 cpm
for the various samples.
Percentage of IL-2 Transcription-positive Cells by In Situ Hybridization
The percentage of cells positive for IL-2 gene expression was determined by in situ hybridi-
zation as described in Materials and Methods . In separate experiments, 7-10 silver grains
per cell was taken as a positive result . Data are the mean f SD of 4-16 determinations .
Total spleen leukocytes were prepared as described in Materials and Methods.
x Low density spleen leukocytes were isolated at the interface of discontinuous 38-54% Per-
coll density gradients .
6 Mice were treated with poly(I :C) 1 .5 d before death .
Effector cells Cell fraction nu/nu
Phenotype
nu/+ SLID
0 /0
Control Unseparated' 2 .6 ± 2.4 3 .2 ± 1 .9 1 .4 ± 1 .9
Low density$ 3 .5 ± 3.3 4 .4 ± 3.6 3 .0 ± 5 .2
Poly(I:C)§ Unseparated' 11 .9 ± 6 .1 5 .9 f 3 .9 14.5 ± 7 .4
Low densityt 20.4 ± 8.6 18 .9 t 7 .6 33.8 f 3 .0KASAIAN AND BIRON
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companiedby the activation ofIL-2 gene expression in both athymic and euthymic
mice. These data demonstrate that the major responding cell type is not a T cell.
To further define the cellular basis of the IL-2 response to poly(I:C), SLID mice
were treated with the IFN inducer. Although SLID mice are deficient in both T
and B lymphocytes, they do contain full NK cell activity (25, 26). In these experi-
ments, poly(I:C)treatmentdramatically elevated the lysis of NK-sensitive target cells
by spleen leukocytes of SCID mice, from undetectable activity in control animals,
to 19 LU/spleen in mice treated with poly(I:C). This increase in NK cell activity
was accompanied by the induction of IL-2 gene expression. In situ hybridization
demonstrated that the percentage of IL-2-expressing cells increased from 1.4% in
untreated to 14.5% after poly(I:C) treatment of SCID mice (Table III).
To enrich theIL-2-transcribingcell, low densitypopulations containing activated
cells were prepared from control and poly(I:C)-treated mice. Greater than 18% of
the low density cells isolated from poly(I :C)-treated athymic, euthymic, or SCID
mice were positive for IL-2 gene expression (Table III; Fig. 4). The spleen leuko-
cytes of SCID mice contained a large number of cells with the doughnut-shaped
nuclear morphology characteristic of granulocyte precursors. Although these cells
were abundant in thelowdensityfraction (Fig. 4, c and d), the granulocyteprecursors
were distinctly negative for IL-2 gene expression when isolated from either control
or poly(I:C)-treated mice (Fig. 4, c and d). These findings demonstrate the induc-
tion of IL-2 gene expression in apopulation of low density spleen cells afterexposure
to IFN, and indicate that the transcription-positive cell type is not a T cell, B cell,
or granulocyte.
CsA Effects on Ibb<TC)-inducedIL-2 Gene Transcription.
￿
IL-2 production is inhibited
in vitro (18, 19) and in vivo (14) at the levelof gene transcription by the immunosup-
pressive drug CsA. To determine whether the IL-2 gene expression induced by
poly(I:C)treatmentis CsA sensitive, this drug wasadministered to poly(I:C)-treated
athymic mice. The percentages of IL-2 transcript-positive cells in the low density
population were reduced by 85-100% as a result of CsA treatment (Fig. 5). Anti-
viral IFN is resistant to CsA (27), and poly(I:C)-induced IFN levels in the serum
were not affected by drug treatment.
CsA Effects on NK CellActivity.
￿
To determinethe consequences ofloss of IL-2 tran-
scription on NK cell-mediated lysis, spleen leukocytes of athymic mice treatedwith
poly(I:C)in thepresence or absenceofCsAwere used in acytotoxicity assay against
YAC-1 target cells. An apparent increase in cytotoxicity after CsA treatment was
observed (Fig. 6 a). Cells of poly(I :C)-treated mice mediated 13.5% lysis at an E/T
of 25 :1, as compared with 21% for cells isolated from mice given CsA in addition
to poly(I :C). The enhanced activity proved to be artificial, however, as spleen leuko-
cyte yields were decreased by 42% in CsA-treated animals. When the number of
LU per spleen was calculated, no effect of CsA on the level of NK cell activity was
evident; poly(I:C)-treated animalshad 17 LU/spleen, as compared with 15 LU/spleen
for mice given poly(I:C) and CsA. Thus, the level of NK cell activity per spleen
was unchangedby CsA treatment. These results demonstrate that IFN-induced NK
cell activity is independent of IL-2, and of other CsA-sensitive agents.
CsA Effects on NK Cell Blastogenesis and Proliferation.
￿
To evaluate the effects of CsA
on poly(I :C)-induced NK cell expansion, LGL numbers and [3H]thymidine incor-
poration by the NK cell population of CsA-treated nude mice were analyzed. CsA
treatment did not diminish the recovery of LGLs in the NK cell-enriched Jlld- low754
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FIGURE 4 .
￿
In situ hybridization for IL-2 gene expression in low density spleen cells isolated
from poly(I:C)-treatedmice. In situ hybridizationwasperformedon cells isolated from untreated
and poly(I:C)-treated mice, using a 9SS-labeled cDNA probe to the mouse IL-2 gene . Positive
cells contained seven or more grains . Percentages of positive cells in each fraction are reported
in Table III . Cells were derived from : a, euthymic (nu/+ ) mice, control; b, euthymic (nu/+ )
mice, poly(I:C) treated ; c, athymic (nu/au) mice, control; d, athymic (nu/nu) mice, poly(I:C) treated;
e, SLID mice, control ; f, SCID mice, poly(I:C) treated.KASAIAN AND BIRON
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FIGURE 5 .
￿
In situ hybridization to determine effects of CsA on poly(I:C)-induced IL-2 gene
expression . In situ hybridization wasperformed as described in Materials and Methods, using
low density spleen leukocytes isolated from athymic mice . (a) Control; (b) treated with 100 Rg
poly(I:C) 1.5 d before death ; (c) treated with three dosages of 40 ng/kg CsA at 12-h intervals,
in addition to poly(I:C). Controland poly(I:C)-treated mice were administered olive oil in place
of CsA . (d) The percentage of cells positive for transcription was determined, using a value of
seven or more grains per cell as a positive result. 100 cells were scored per experiment . Data
are presented as mean t SD for three to five separate experiments .
density fraction (Fig . 6 b) . Greater than 70% of the cells in this fraction isolated
from mice treated either with poly(I:C) alone, or with CsA in addition to poly(I:C),
hadLGL morphology. Mice treated with CsA alone had 1.5 x 105 LGLs per spleen,
whereas CsA-treated animals given poly(I:C) had 5.7 x 105 LGLs per spleen . This
represents a three- to fourfold increase in LGL number, indicating that expansion
of LGLs was not inhibited by CsA.
To evaluate effectsofCsA onNK cell blastogenesis and proliferation in response
to poly(I :C), [3H]thymidine incorporation by theJlld- low density population was
assayed. Cells isolatedfrom mice treated withCsA in addition to poly(I:C) incorpo-
rated as much or more [3H]thymidine than did cells isolated from mice that had
received poly(I:C) alone (Fig. 6 c) . Furthermore, examination of [3H]thymidine in-
corporation into individual cells by autoradiography revealed that the percentage
ofcells undergoingDNA synthesis waslargelyunaffected by thedrug (Fig . 7) . These756
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FIGURE 6 .
￿
Effects ofCsAon poly(I:C)-induced
NK cell activity . Spleen leukocytes were prepared
from athymic mice treated with poly(I:C) in the
presence or absence ofCsA, and fractionated as
described in Materials and Methods . Control
animals were administered olive oil only or CsA
only. (a) Cytotoxicity mediated by total plastic
nonadherent splenocytes in a 5-h 5ICr release
assay against YAC-1 target cells. (b) Percentages
of cells with LGL morphology in the Jlld- low
density spleen cell fraction . A total of 200 cells
were scored per sample. Data are presented as
themean +/- SD for five toeight individual ex-
periments . (c) Incorporation of [3Hlthymidine
by Jlld- low density cells in a 6-h pulse . With
the exception ofthe sample from mice treated with
CsA only, data are shown as the mean +/- SD
for 5-10 determinations.
results demonstrate that, although CsA drastically inhibits poly(I:C)-induced IL-2
gene transcription, it does not block NK cell blastogenesis or proliferation .
CsA Effects on IL-2 Responsiveness .
￿
To determine the effects of CsA on IL-2 re-
sponsiveness among the IFN-induced NK cells, cells were isolated from athymic
mice treated with CsA in addition to poly(I :C) . CsA, at concentrations that resulted
in complete inhibition ofIL-2 gene transcription, caused only a moderate reduction
in IL-2 responsiveness (Fig . 8) . These results suggest that IFN-induced NK cells
remain responsive to IL-2 in the presence of CsA .
Discussion
Previous work from this laboratory has shown that IFN and IFN inducers elicit
acuteNK cell blastogenesis and proliferation in vivo. The IFN-elicited effector cells
have been thoroughly characterized . They demonstrate elevated cytolytic activity
against NK-sensitive, but not NK-resistant, target cells (5), have the morphologyKASAIAN AND BIRON
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FIGURE 7 .
￿
Single cell [3Hithymidine incorporation in response to poly(I:C) : lack of inhibition
by CsA. The Jlld- low density populations were isolated from athymic mice treated with
poly(I:C) in the presence or absence ofCsA, as described in Materials and Methods . Cells were
incubated for i h with the DNA precursor, [ 3Hlthymidine, spun onto microscope slides, and
exposed to emulsion . The emulsion was developed after 20 h, and cellswere stained with Wright's-
Giemsa . Cells were derived from : A, control mice ; B, poly(I:C)-treated mice; C, mice treated
with CsA in addition to poly(I:C) ; D, the percentage of cells incorporating [3H]thymidine was
quantitated, of 100 total cells scored per sample .
of LGLs (5), and express a high level of the NK cell surface determinants AGM1
(5) and NK 1.1 (8) . Furthermore, these cells are negative for expression of TCR
genes u, (3, -y, T36, and T3e (9) . The activatedNK cells are clearly dividing, as they
are driven into the S and G2/M phases of cell cycle (8, 9), incorporate the DNA
precursor, [3H]thymidine (3, 6), and increase in number (8) . In the studies reported
here, blast NK cells were isolated in J11d- low density populations prepared from
poly(I :C)-treated athymic mice . The dividing cells were characterized as NK cells
based on the findings that they were eliminated by anti-AGMI treatment in vivo,
and that the [3H]thymidine-incorporating cells directly mediated lysis of NK-
sensitive target cells . The goal of the present studies was to assess the requirement
for IL-2 during IFN-elicitedNK cell proliferation . Studies presented here suggest
that IL-2 may be induced after exposure to IFN in vivo, but show that the factor
is not necessary to support NK cell proliferation .
We have previously examined the IL-2-dependent expansion of T lymphocytes758
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FIGURE 8.
￿
CsA effects on the IL-2 responsive-
ness of poly(I:C)-induced blast cells . Jlld- low
density populations were incubated with 5 x 103
U/ml rIL-2 for 24 h, as described in Materials
and Methods . [ 3H]thymidine (1 uCi/well) was
added durimthe final 6 h of incubation . Incor-
poration of ( H]thymidine by the cells was as-
sayed by liquid scintillation counting.
duringLCMV infection in vivo (14) . In those studies, treatment with the immunosup-
pressive agent, CsA, blocked IL-2 transcription and production, as well as T cell
activation and proliferation during infection (14) . In contrast, NK cell cytolytic ac-
tivity was elevated in the virus-infected mice treated with CsA at times when T cell
activity and IL-2 transcription were inhibited . This result suggested that NK cell
proliferation might beCsA insensitive and IL-2 independent . Although IL-2 is able
to directly induce NK cell proliferation in vivo and in vitro (10-12), and is the only
factor currently described to have these properties, its involvement in a normal in
vivoNK cell-proliferative response has notbeen previously addressed . The present
study directly examined the role of IL-2 in IFN-induced NK cell proliferation in
a T cell-independent system . Although poly(I :C) treatment resulted in IL-2 gene
transcription, IL-2 was not found to be an important mediator ofNK cell prolifera-
tion . CsA treatment completely inhibited IL-2 transcription, but did not blockNK
cell expansion . These results demonstrate that acute NK cell proliferation is IL-2
independent and CsA insensitive .
Although NK cell expansion occurred in the absence of IL-2 gene transcription
in vivo, our results demonstrate that IFN-elicited blastNK cells areable to proliferate
in response to exogenous IL-2 in vitro. This suggests expression of an IL-2 binding
site on IFN-activatedNK cells. The receptor for IL-2 consists of two subunits : the
low affinity p55, cx chain molecule, and the intermediate affinity p70/75, R subunit
(28, 29) . A high affinity binding site results from interaction of these two subunits,
and is thought to mediate the response ofT lymphocytes to IL-2 . Although aprolifer-
ative signal is transduced most efficiently by the high affinity receptor, the p70/75
molecule is able to independently deliver a growth signal (30) . Recent work from
other laboratories suggests thatNK cellsmay constitutively express the p70/75 mole-
cule on the cell surface (31-34) . The p55 chain is not sufficient to mediate a cellular
response to IL-2 . We have recently shown that murine NK cells elicited in vivo in
response to either IFNor IL-2 do not express detectable levels ofthe p55 chain gene
(8), and thus cannot form the high affinity receptor. The results reported here are
consistent with lack of expression ofa high affinity IL-2-R by in vivo activated NK
cells . The IFN-elicited blast NK cells requird -1,000-fold higher concentrations of
IL-2 to achieve a half-maximal proliferative response than did blast lymphocytes
of mice undergoing a T cell response to LCMV This concentration dependenceKASAIAN AND BIRON
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is consistent with NK cell expression ofa lower affinity receptor form than that ex-
pressed on T cells, and may reflect use of the p70/75 molecule.
TheJlld- low density populations isolated from untreated control mice were also
able to proliferate in response to exogenous IL-2 in vitro. However, this response
required extremely high concentrations of IL-2 (>5 x 105 U/ml). The increased re-
sponsiveness ofJ11d- lowdensity cells isolated from poly(I:C)-treated mice, as com-
paredwith that ofcontrolmice, maybe explained by anyofthe following: (a)expan-
sion of the IL-2-responsive cell type; (b) increased numbers of receptors per cell;
and (c) expression ofa higher affinity form ofthe receptor. Additional information
concerning the kinetics ofIL-2 binding by NK cells is required to distinguish be-
tween these possibilities.
It is not clear whether or not the IL-2 transcription observed in spleen cells of
poly(I :C)-treated mice is accompanied by synthesis of functional IL-2. It was not
possible to detect IL-2 production in response to poly(I:C), even in the low density
lymphocytefraction enriched fortranscription-positive cells(datanotshown). However,
this may be due to technical limitations ofthe IL-2 production assay. The produc-
tion ofIL-2 is determined as therelease offunctionalIL-2 intosupernatants ofover-
night leukocyte cultures (13). As the IL-2-producing cells may also bind and use
the factor, demonstration of production requires inhibition of IL-2 consumption
by the producing cells. Inhibition has been achieved previously by addition ofanti-
bodies directed against the p55 chain ofthe IL-2-R (13). Ifthe IL-2-producing cells
express p70/75 only, and do not use the p55 chain, IL-2 utilization would not be
prevented by anti-p55 antibodies. Experiments are in progress to characterize anti-
bodies directed against p70/75, which may then be evaluated for their ability to in-
hibit IL-2 consumption in this system.
Despite thelackofdemonstrable product, the in situ hybridization studies clearly
revealed poly(I :C)-induced activation ofIL-2 gene expression. This expression was
CsA sensitive, and wasfound in spleen cells isolated from poly(I:C)-treated euthymic,
athymic, and SCID mice. These findings suggest that a source ofIL-2 exists in vivo
other than the mature T cell. Although the positive cells have yet to be identified,
preliminary studies suggest that IL-2-transcribing cells can be found in both J11d+
andJlld- low density populations. The frequency of the IL-2-transcribing cell in
the J11d- low density fraction appears to be higher in athymic mice as compared
with euthymic mice. Experiments are in progress todefinitively characterize the cell
type responsible for IL-2 transcription in this system.
Taken together, the following observations suggest that although IL-2 gene ex-
pression is induced by poly(I :C), itisunlikely that IL-2 plays acritical role in medi-
atingthe NKcell response to IFN. (a) The percentage ofunfractionated spleen leu-
kocytes expressing the IL-2 gene in response to poly(I:C) is low. (b) CsA blocked
IL-2 genetranscription, but not NKcellcytotoxicity orexpansion, conclusively demon-
strating that the IL-2 gene expression in response to poly(I:C) is not necessary to
drive NK cell blastogenesis or proliferation. (c) although poly(I :C) induced IL-2
responsiveness amongtheJlld- low density population enriched for blast NK cells,
this response required very high concentrations of the lymphokine (>2.5 x 103
U/ml). Such high levels of IL-2 are not likely to be physiological. Thus, if IL-2 is
involved in the invivoresponse toIFN, it mayinteract withacelltype otherthanNK.760
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It was observed that treatment ofathymic mice with CsA alone induced a cytopenia
in the spleen, indicating that one or more cell types in this system are influenced
by CsA-sensitve agents. IL-2 is thought to influence the process of NK cell matura-
tion from hematopoietic precursors(35-37). Our findings address only acute changes
in NK cell number and function resulting from CsA treatment, rather than effects
of long-term CsA administration. Potential CsA effects on NK cells or other cell
types may be more apparent at the level of lymphocyte homeostatis, rather than
IFN-induced activation.
In conclusion, this report has documented that IFN-induced NK cells are respon-
sive to IL-2, and that IL-2 gene expression is activated in mice treated with an IFN
inducer. The results demonstrate that IFN-induced NK cell proliferation is IL-2
independent, however, as CsA administration blocked IL-2 transcription, but did
not affect NK cell activation or expansion in response to poly(I:C). These results
demonstrate the IL-2 independence of NK cell activation in response to IFN, and
establish the CsA insensitivity of the signals produced in vivo to mediate NK cell
proliferation.
Summary
The IFN inducer, poly(I:C), elicits acute NK cell blastogenesis and proliferation
in vivo. The role of IL-2 in mediating this proliferation was investigated in the studies
presented here. Blast NK cells were isolated from poly(I:C)-treated, T cell-deficient
athymic mice. Dividing cells, incorporating [3H]thymidine, were enriched in the
Jlld - low density populations isolated from poly(I :C)-treated mice, and were char-
acterized as NK by the following criteria: (a) they were eliminated by treatment with
anti-AGMI in vivo; and (b) they directly mediated lysis of NK-sensitive target cells
in a single cell cytotoxicity assay with autoradiography. These poly(I :C)-induced
blast NK cells were responsive to IL-2, but, when compared with in vivo activated
T cells, responsiveness required 1,000-fold higher concentrations of the factor.
The technique of in situ hybridization was used to evaluate induction ofIL-2 gene
expression after poly(I :C) treatment in vivo. Treatment of euthymic, athymic, and
severe combined immunodeficient mice with poly(I:C) activated IL-2 gene expres-
sion in a small percentage of spleen leukocytes. The transcription-positive cellswere
enriched in low density cell populations. These findings demonstrate that IL-2 tran-
scription occurs after IFN induction in vivo, and suggest that an endogenous source
of IL-2 exists other than the mature T cell. To assess the IL-2 dependence of in
vivo NK cell expansion, poly(I:C)-treated athymic mice were given cyclosporin A
(CsA), an agent that regulates IL-2 production at the level of gene transcription.
The drug resulted in an 85-100% reduction in the percentages of cells transcribing
IL-2 . In contrast, CsA administration did not block IFN-enhanced NK cell cyto-
lytic activity, expansion of large granular lymphocyte numbers, or NK cell prolifer-
ation. These findings demonstrate that although the proliferation of blast NK cells
can be supported by IL-2, IL-2 is not an important mediator of IFN-induced NK
cell expansion. Moreover, they establish that the acute proliferation of NK cells in
response to IFNs is CsA insensitive.
We thank Dr. Joan Stein-Streilein for the generous gift of the SLID mice.
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